
|Articles|August 15, 2003
STAAR's ICL wins spot on FDA's fast-track list
Monrovia, CA-The FDA is studying STAAR Surgical Co.'s implantable contact lens (ICL) under an expedited review status that calls the product a potentially revolutionary advance over the current market.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
2
4DMT releases positive interim 1.5- to 3.5-year data from phase 1/2 PRISM trial
3
AAO 2025: A study of retinal vasculitis events with intravitreal agents
4
PolyActiva and RareSight partner to develop treatments for rare pediatric retinal diseases
5


















































.png)


